SOURCE: Mobiquity, Inc.

Mobiquity, Inc.

February 09, 2015 13:06 ET

Mobiquity Invests $20 Million in London Healthcare, Joins London Mayor in MedCity Initiative and Gilead Sciences

BOSTON, MA--(Marketwired - Feb 9, 2015) - Mobiquity (www.mobiquityinc.com), a mobile engagement provider, today announced that it is investing $20 million over the next two years to expand its offices to London. Coinciding with the Mayor of London Boris Johnson's visit to Boston, Mobiquity's expansion aims to tap into London's strengths in digital health. The company is currently working with Pfizer in the UK to create digital technologies that will deliver better patient outcomes and allow them to manage their own health.

Additionally, Gilead Sciences, a Fortune 500 U.S. biotechnology company, has also announced that it will create a new UK commercial headquarters in Holborn, alongside expanding its international operations in Uxbridge and UK research and development headquarters in Cambridge.

"London and Boston are two of the greatest scientific cities on the planet and our phenomenal research institutions are collaborating closely to help spur the discovery of new treatments to tackle disease," said Johnson. "Gilead and Mobiquity's moves to London further underline the growing importance of the life sciences industry in the UK as we look to ensure that this crucial sector becomes a key contributor to the capital's growth and health."

"We are very excited to extend our healthcare expertise in London," said Mobiquity founder and CEO, Bill Seibel. "Mobile health is an area that is growing rapidly, and there is enormous potential in the UK with the innovative activity and strong leadership of its Mayor."

"The UK and USA are well-matched life sciences partners, and I'm delighted to see the traffic across the Atlantic increasing," said Dr. Eliot Forster, Executive Chair of MedCity. "London and the south east are in the midst of a sustained period of growth and investment in life sciences, and that is attracting great people and companies who enrich our ecosystem further. Gilead and Mobiquity are excellent examples -- different companies with different focuses, both at the forefront of the changing healthcare environment."

About MedCity

Established by the Mayor of London with the capital's three Academic Health Science Centres -- Imperial College Academic Health Centre, King's Health Partners, and UCL Partners -- MedCity is a unique collaboration that brings together the outstanding life sciences strengths of London and the greater south east. Over the next 20 years, MedCity will position the region as a world-leading, interconnected hub for research, development, manufacturing and commercialisation by championing collaboration and entrepreneurship, promoting a joined up and globally distinct life sciences offer, and providing a visible 'go-to' point for industry and investors. www.medcitylondon.com

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California. For more information: http://www.gilead.com/.  

About Mobiquity, Inc.

Mobiquity is a mobile engagement provider creating innovative solutions that drive business value. Because mobile is in our DNA, clients benefit from how we expertly and effectively blend the three key disciplines that unleash the power and innovation of mobile computing: strategy, user-centered design and core technology. Since inception in 2011, we have worked with more than 200 companies, including CVS, Fidelity Investments, Ziggo, MetLife, the New York Post, Pfizer, Medavie Blue Cross, The Weather Channel, Putnam Investments, KPN, The Boston Globe and Weight Watchers International. To learn more, visit: http://www.mobiquityinc.com/.